LEN and pomalidomide can downgrade the expression of CCR5 and increase interferon regulatory factor 8 (IRF8) in the mRNA level in peripheral blood mononuclear cells (PBMCs) while also hindering the expression of CCL5 in MM cells. Here, CCR5 is linked to Miyoshi myopathy.